Only a matter of time, no? I imagine the next big money is in the LVAD field with THOR (or someone else...), transplant meds, and if someone could make better Sedation without delirium or hypotension, that'd be huge too!The stalwarts aren't going anywhere, just like in most industries, unless they really, really, screw up. MABs, with their excessive difficulty to make as a generic, provides a nice cash cushion for many a biotech/pharma.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra